Bile Acid Metabolism – Function and Clinical Role

What Is Bile Acid Metabolism?

Bile acid metabolism encompasses all biochemical processes involved in the synthesis, transport, conjugation, reabsorption, and excretion of bile acids. Bile acids are steroid-derived molecules produced in the liver from cholesterol. They play a central role in the digestion and absorption of dietary fats, as well as in the regulation of cholesterol levels and various metabolic pathways.

Bile acid metabolism is closely linked to the function of the liver, gallbladder, and intestine, and also influences broader metabolic processes such as glucose regulation and energy homeostasis.

Synthesis of Bile Acids

The primary bile acids – cholic acid and chenodeoxycholic acid – are synthesized exclusively in the liver from cholesterol via two main pathways:

• Classical (neutral) pathway: Initiated by the enzyme CYP7A1 (cholesterol 7-alpha-hydroxylase), this is the predominant route in adult humans.
• Alternative (acidic) pathway: Begins with oxidation of the cholesterol side chain and is less significant in adults but plays a greater role in newborns.

Following synthesis, primary bile acids are conjugated in the liver with the amino acids glycine or taurine, forming more water-soluble compounds known as conjugated bile acids. These are stored in the gallbladder and secreted into the small intestine after a meal.

Transport and Function in the Intestine

Conjugated bile acids are released via the bile ducts into the duodenum (the first part of the small intestine), where they fulfil their primary function: the emulsification of dietary fats. As amphiphilic molecules – possessing both water-attracting and fat-attracting regions – they surround fat droplets to form structures called micelles, which enable the efficient absorption of fats and fat-soluble vitamins (A, D, E, K) through the intestinal wall.

Further along the intestine, gut bacteria convert primary bile acids into secondary bile acids. The most important secondary bile acids are deoxycholic acid (derived from cholic acid) and lithocholic acid (derived from chenodeoxycholic acid).

The Enterohepatic Circulation

A key principle of bile acid metabolism is the enterohepatic circulation. Approximately 95% of the bile acids secreted into the intestine are actively reabsorbed in the terminal ileum (the last section of the small intestine) and transported back to the liver via the portal vein, where they are reconjugated and re-secreted into bile.

This cycle is completed 6 to 10 times per day. The body maintains a total bile acid pool of approximately 2 to 4 grams, even though 12 to 32 grams are secreted daily, thanks to this efficient recycling mechanism. Only about 5% of bile acids are lost through fecal excretion each day and must be replaced by new hepatic synthesis from cholesterol.

Regulation of Bile Acid Metabolism

Bile acid synthesis is regulated through a complex feedback system. The most important regulatory mechanism involves the farnesoid X receptor (FXR), a nuclear receptor activated by bile acids. When bile acid concentrations are high, FXR suppresses the expression of CYP7A1, thereby reducing further synthesis.

Additionally, the intestinal hormone FGF19 (fibroblast growth factor 19) plays an important role: it is released from the ileum following bile acid absorption and sends an inhibitory signal to the liver to reduce bile acid production.

Clinical Relevance and Associated Conditions

Disruptions in bile acid metabolism can contribute to a range of medical conditions:

• Cholelithiasis (gallstones): An imbalance between bile acids, cholesterol, and phospholipids in bile can lead to the crystallization and formation of gallstones.
• Cholestasis: Impaired bile flow leads to the accumulation of bile acids in the liver and bloodstream, causing liver cell damage and jaundice.
• Bile acid malabsorption (bile acid diarrhea): Caused by impaired reabsorption of bile acids in the ileum – for example, following ileal resection or in the context of Crohn's disease – resulting in chronic diarrhea.
• Primary biliary cholangitis (PBC): An autoimmune disease in which the bile ducts within the liver are inflamed and progressively destroyed, severely disrupting bile flow and bile acid metabolism.
• Metabolic syndrome: Alterations in bile acid metabolism are increasingly associated with insulin resistance, obesity, and non-alcoholic fatty liver disease (NAFLD).

Therapeutic Approaches

Understanding bile acid metabolism has led to the development of several important therapeutic strategies:

• Bile acid sequestrants (cholestyramine, colesevelam): Bind bile acids in the intestine and prevent their reabsorption, thereby increasing cholesterol utilization for new bile acid synthesis and lowering blood cholesterol levels.
• Ursodeoxycholic acid (UDCA): A hydrophilic, hepatoprotective bile acid used in the treatment of primary biliary cholangitis and other cholestatic liver diseases.
• FXR agonists (e.g., obeticholic acid): Activate the FXR receptor and are being investigated for the treatment of primary biliary cholangitis and non-alcoholic steatohepatitis (NASH).

References

1. Chiang, J. Y. L. (2013). Bile acid metabolism and signaling. Comprehensive Physiology, 3(3), 1191–1212. PubMed PMID: 23897689.
2. Russell, D. W. (2003). The enzymes, regulation, and genetics of bile acid synthesis. Annual Review of Biochemistry, 72, 137–174.
3. European Association for the Study of the Liver (EASL). EASL Clinical Practice Guidelines on the prevention, diagnosis and treatment of gallstones (2016). Journal of Hepatology, 65(1), 146–181.